azacitidine has been researched along with Constriction, Pathologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, QL; Huang, CS; Liu, C; Wang, Y; Yan, JQ; Zhu, XY; Zou, WY | 1 |
1 other study(ies) available for azacitidine and Constriction, Pathologic
Article | Year |
---|---|
Intrathecal 5-azacytidine inhibits global DNA methylation and methyl- CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic constriction injury.
Topics: Analysis of Variance; Animals; Azacitidine; Chronic Disease; Constriction, Pathologic; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Functional Laterality; Gene Expression Regulation; Injections, Spinal; Male; Methyl-CpG-Binding Protein 2; Neuralgia; Pain Measurement; Rats; Rats, Sprague-Dawley; RNA, Messenger; Time Factors | 2011 |